The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Allergan plc

NYSE: AGN
Last

(U.S.) $331.15

Today's change+2.28 +0.69%
Updated July 31 4:05 PM EDT. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $331.15

Today's change+2.28 +0.69%
Updated July 31 4:05 PM EDT. Delayed by at least 15 minutes.

Allergan plc up (U.S.)$2.28

Allergan plc closed up Friday by (U.S.)$2.28 or 0.69% to (U.S.)$331.15. Over the last five days, shares have gained 7.44% and are currently 2.70% off of the 52-week high. Shares have outperformed the S&P 500 by 45.58% during the last year.

Key company metrics

  • Open(U.S.) $328.50
  • Previous close(U.S.) $328.87
  • High(U.S.) $332.48
  • Low(U.S.) $326.29
  • Bid / Ask(U.S.) $331.10 / (U.S.) $349.00
  • YTD % change+28.65%
  • Volume2,885,591
  • Average volume (10-day)2,936,984
  • Average volume (1-month)2,262,152
  • Average volume (3-month)2,152,244
  • 52-week range(U.S.) $201.91 to (U.S.) $340.34
  • Beta0.33
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward18.46×
  • Forward PEG1.30×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$8.49
Updated July 31 4:05 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue4,2344,0573,6832,667
Total other revenue--------
Total revenue4,2344,0573,6832,667
Gross profit2,5212,2261,8001,371
Total cost of revenue1,7131,8311,8831,297
Total operating expense4,5564,6824,7052,482
Selling / general / administrative1,4291,1981,275527
Research & development431468697158
Depreciation / amortization925877874423
Interest expense (income), net operating--------
Unusual expense (income)58308-2378
Other operating expenses, total--------
Operating income-322-625-1,022185
Interest income (expense), net non-operating-172-128-132-79
Gain (loss) on sale of assets--------
Other--------
Income before tax-690-795-1,15192
Income after tax-512-733-1,04349
Income tax, total-178-62-10844
Net income-512-733-1,04349
Total adjustments to net income-23------
Net income before extra. items-512-733-1,04349
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-535-733-1,04349
Inc. avail. to common incl. extra. items-535-733-1,04349
Diluted net income-535-733-1,04349
Dilution adjustment0--00
Diluted weighted average shares290266264175
Diluted EPS excluding extraordinary itemsvalue per share-1.85-2.76-3.950.28
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-1.72-2.00-4.000.51